Markets
markets
Luke Kawa

Nvidia is about to deliver “a wake-up moment for the tech bulls,” analysts say

Nvidia CEO Jensen Huang takes the stage at 1 p.m. ET this afternoon to deliver the keynote address at the chip designer’s GTC event.

The Street is looking for the unveiling of a new flagship AI chip and more details on its product road map. After Nvidia’s guidance in late February failed to put a floor under the stock, some analysts like Wedbush’s Dan Ives are expecting that this event will provide a swell of optimistic commentary about the company’s prospects that reinvigorates investors’ enthusiasm for the $2.9 trillion company.

Ives called this conference “a wake-up moment for the tech bulls” that will put “focus back on the AI revolution.”

“Jensen we expect will discuss Blackwell ‘off the charts demand’ from enterprise customers as Nvidia is the hearts and lungs of enterprise and consumer AI use cases forming around the globe,” he added. “We also expect Jensen to discuss next-gen Rubin architecture, Quantum computing, lingering worries about DeepSeek, and also focus on the physical AI future with autonomous and robotics the holy grail of AI use cases.”

Nvidia is no longer that expensive of a stock, Ives argued — and indeed, its forward price-to-earnings multiple is just over 25, hovering near multiyear lows. The company is poised to be a prime beneficiary of what he believes will be $2 trillion in capex linked to AI over the next three years.

Other analysts, like Bank of America’s Vivek Arya, have also been touting this conference as a potential bullish catalyst for the stock. Even with Nvidia’s recent travails, it’s still beloved by the sell-side community.

Shares of the chip designer bounced nearly 14% off their lows of the year to end last week, but gave some back with a 1.8% decline on Monday, even as the VanEck Semiconductor ETF and Nasdaq 100 rose on the session.

Like most of the so-called Magnificent 7, the stock is down on the year and lagging the S&P 500 over the past three months.

More Markets

See all Markets
markets
Luke Kawa

Strategy jumps as MSCI allows digital asset treasury companies to stay in global indexes

In a massive reprieve for Strategy, index provider MSCI is letting digital asset companies stay in its benchmarks, sending shares sharply higher in after-hours trading.

The index provider had floated a proposal in which firms where crypto holdings are more than 50% of assets would be excluded from its global indexes, but has decided not to proceed with this for now.

“MSCI has determined at this time not to implement the proposal to exclude digital asset treasury companies (‘DATCOs’) from the MSCI Global Investable Market Indexes (‘MSCI Indexes’) as part of the February 2026 Index Review,” per a statement.

Getting kicked out of key indexes would have caused funds to flow out of Strategy, the largest digital asset treasury company, and its peers.

“At this time,” of course, means the door is open to reconsidering this down the road, as MSCI plans on having a broader review and consultation on the treatment of DAT companies.

“Distinguishing between investment companies and other companies that hold non-operating assets, such as digital assets, as part of their core operations rather than for investment purposes requires further research and consultation with market participants,” according to MSCI.

markets
Matt Phillips

Rocket Lab surges to second straight record-high close

Retail favorite Rocket Lab closed at a new all-time high on Tuesday, continuing a remarkable run over the last month that has carried the launch services provider and aspiring Space X competitor up more than 70% over the last month (compared to its close of $49.06 on December 5).

Rocket Lab saw elevated options activity during its run-up today, with well over 3.5x the 90-day average in options volume changing hands over the course of the day.

Other space plays such as AST SpaceMobile and EchoStar surged today.

Despite being a money-losing company — it’s never turned an annual profit as a public company — Rocket Lab’s share price has soared nearly 1,500% over the last two years, generating tons of loyalty and enthusiasm among retail investors.

In fact, Goldman Sachs has made Rocket Lab the heaviest weighting in the latest iteration of its GS Memes basket of thematic stocks, just ahead of AST SpaceMobile, showing how enamored traders have become of such space stocks.

CHICAGO, IL - MARCH 05: Benny, the mascot for the Chicago Bulls entertains during a break between the Bulls and the Boston Celtics at the United Center on March 5, 2018 in Chicago, Illinois.

The S&P 500 closes at a record high

The Nasdaq 100 and Russell 2000 outperformed, rising 0.9% and 1.4%, respectively.

Tasha Matsumoto2h
markets
Max Knoblauch

JetBlue takes off on bullish options activity

Low-cost airline JetBlue is up more than 8% on Tuesday, on pace for its biggest daily gain since August. If the price momentum holds, Tuesday will mark JetBlue’s sixth-best trading day of the past 52 weeks.

The carrier is being propelled by bullish options activity, with more than 53,000 call options changing hands as of 12:14 p.m. ET, nearly 4x the 20-day average for a full session.

JetBlue closed up 4.6% on Monday, as traders appeared to price in medium-term oil supply relief due to the possibility of Venezuela’s reserves getting more developed amid tensions with the US.

markets
J. Edward Moreno

Moderna rallies after BofA raises its price target to $24 from $21

Moderna rose on Tuesday after Bank of America analysts raised their price target for the ailing biotech behind the COVID-19 vaccine, painting a rosy picture of the products in its pipeline.

BofA kept Moderna’s “underperform” rating but raised its price target to $24 from $21, which now accounts for “refreshed revenue builds for lead assets.” Analysts said the company’s cost-cutting measures, paired with potential new revenue from its investigatory oncology vaccines, could bring it back to profitability in the coming years.

Moderna is best known for being tapped by the US government to quickly develop a vaccine for COVID-19 in 2020, a product that remains its single source of revenue. The company has yet to bring new products to market and is now faced with a second Trump administration hostile to that product.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.
©2026 Sherwood Media, LLC